Portage Historical Income Statement
| PRTG Stock | USD 4.13 0.10 2.48% |
Historical analysis of Portage Biotech income statement accounts such as Cost Of Revenue of 51.3 K, Interest Expense of 30.4 K, Selling General Administrative of 3.6 M or Selling And Marketing Expenses of 12.3 K can show how well Portage Biotech performed in making a profits. Evaluating Portage Biotech income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Portage Biotech's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Portage Biotech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Portage Biotech is a good buy for the upcoming year.
Portage |
About Portage Income Statement Analysis
Portage Biotech Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Portage Biotech shareholders. The income statement also shows Portage investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Portage Biotech Income Statement Chart
Add Fundamental
Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Portage Biotech. It is also known as Portage Biotech overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from Portage Biotech operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Portage Biotech is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Minority Interest
Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of Portage Biotech whose combined shares represent less than 50% of the total outstanding shares issued by Portage Biotech have a minority interest in Portage Biotech.Most accounts from Portage Biotech's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Portage Biotech current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Portage Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Portage Stock please use our How to Invest in Portage Biotech guide.At this time, Portage Biotech's Net Interest Income is most likely to increase significantly in the upcoming years. The Portage Biotech's current Interest Income is estimated to increase to about 287.7 K, while Operating Income is forecasted to increase to (17.3 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Other Operating Expenses | 15.6M | 16.6M | 18.3M | 19.2M | Depreciation And Amortization | 15.6M | 1K | 54K | 51.3K |
Portage Biotech income statement Correlations
Click cells to compare fundamentals
Portage Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Portage Biotech income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 206.3K | 12.2M | 15.6M | 1K | 54K | 51.3K | |
| Other Operating Expenses | 6.0M | 12.4M | 15.6M | 16.6M | 18.3M | 19.2M | |
| Operating Income | (6.0M) | (12.4M) | (15.6M) | (16.6M) | (18.3M) | (17.3M) | |
| Ebit | (6.2M) | (26.4M) | (31.2M) | (15.8M) | (18.3M) | (17.3M) | |
| Ebitda | (5.9M) | (14.2M) | (15.7M) | (15.8M) | (18.2M) | (17.3M) | |
| Total Operating Expenses | 6.0M | 12.4M | 15.6M | 16.6M | 18.2M | 19.1M | |
| Net Income | (7.2M) | (17.2M) | (19.2M) | (104.6M) | (75.3M) | (71.6M) | |
| Income Tax Expense | 2.2M | 2.3M | 4.4M | (17.9M) | (10.5M) | (11.1M) | |
| Interest Expense | 88K | 557K | 177K | 43K | 9K | 30.4K | |
| Income Before Tax | (5.1M) | (14.9M) | (14.8M) | (122.5M) | (85.7M) | (81.4M) | |
| Total Other Income Expense Net | 894K | (2.5M) | 771K | (105.9M) | (67.4M) | (64.1M) | |
| Selling General Administrative | 1.9M | 5.1M | 8.8M | 8.4M | 5.7M | 3.6M | |
| Research Development | 4.1M | 7.3M | 6.8M | 8.2M | 12.5M | 8.1M | |
| Net Interest Income | (546K) | (177K) | (43K) | 208K | 242K | 254.1K | |
| Net Income From Continuing Ops | (7.2M) | (17.2M) | (19.2M) | (104.7M) | (75.4M) | (71.6M) | |
| Net Income Applicable To Common Shares | (2.6M) | (5.3M) | (15.8M) | (16.9M) | (15.2M) | (14.4M) | |
| Minority Interest | 49.1M | 46.2M | 2.3M | 55K | 43K | 40.9K |
Currently Active Assets on Macroaxis
When determining whether Portage Biotech is a strong investment it is important to analyze Portage Biotech's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Portage Biotech's future performance. For an informed investment choice regarding Portage Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Portage Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Portage Stock please use our How to Invest in Portage Biotech guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Portage Biotech. If investors know Portage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Portage Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (68.17) | Return On Assets (0.19) | Return On Equity (1.91) |
The market value of Portage Biotech is measured differently than its book value, which is the value of Portage that is recorded on the company's balance sheet. Investors also form their own opinion of Portage Biotech's value that differs from its market value or its book value, called intrinsic value, which is Portage Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Portage Biotech's market value can be influenced by many factors that don't directly affect Portage Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Portage Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Portage Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Portage Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.